Dorsey Wright & Associates X Biotech Inc. Transaction History

Dorsey Wright & Associates

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Jan 28, 2021	SELL	$15.65 - $19.92 $8,106 - $10,318	-518 Closed	0 $0
Q3 2020 Oct 28, 2020	SELL	$13.97 - $21.16 $2,416 - $3,660	-173 Reduced 25.04%	518 $10,000
Q2 2020 Jul 23, 2020	BUY	$10.39 - $16.07 $7,179 - $11,104	691 New	691 $10,000
Q3 2019 Oct 31, 2019	SELL	$6.86 - $10.46 $7,203 - $10,983	-1,050 Closed	0 $0
Q2 2019 Jul 02, 2019	BUY	$6.99 - $11.27 $7,339 - $11,833	1,050 New	1,050 $8,000

4.87M

Ticker XBIT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,439,300
Market Cap $194M
Description
XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of product candidates targeting both inflammatory and infectious diseases. It is also developing interleukin-1 alpha therapies to treat variety of medical...

Get notified when there are updates to the investment portfolio of Dorsey Wright & Associates, based on Form 13F filings with the SEC.

Stay updated on Dorsey Wright & Associates with notifications on news.